QUANTUM BIOPHARMA LTD (QNTM) Stock Income Statement
NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 180.70K | 66.50K | 0.00 | |||
| Cost Of Goods | N/A | N/A | 1.39M | N/A | N/A | |||
| Gross Profit | N/A | N/A | -1.21M | N/A | N/A | |||
| Operating Expenses | 33.74M | 29.84M | 23.85M | 24.62M | 2.66M | |||
| Research and Development | 6.33M | 7.83M | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 23.37M | 18.11M | 21.64M | 18.86M | 2.66M | |||
| Operating Income | -33.74M | -29.84M | -25.06M | -24.55M | -2.66M | |||
| Interest Income/Expense | -195.60K | 2.24M | -10.93M | 7.54M | N/A | |||
| Other Income/Expense | 1.30K | 3.70K | 88.20K | N/A | 19.40K | |||
| Non Recurring Items | 0.00 | -847.70K | -650.90K | N/A | N/A | |||
| Income Before Taxes | -33.94M | -28.45M | -36.55M | -17.01M | -2.64M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -35.29M | -31.80M | -36.55M | -17.01M | -2.64M | |||
| EBITDA | -29.70M | -25.94M | -22.70M | -24.41M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -65.65 | -171.66 | -336.81 | -2.88 | -0.40 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | -670.56% | N/A | N/A | |||
| Profit Margin | N/A | N/A | -20227.89% | -25579.55% | N/A | |||
| Operating Profit Margin | N/A | N/A | -13867.85% | -36915.64% | N/A | |||
All data in USD